Company / Return on Assets (ROA)
UTAH MEDICAL PRODUCTS INC Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
13.6%
FY2025
5-year range
2.7% / 13.6%
FY2021-FY2025
Trend
+1.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has increased for 3 consecutive years, from 2.7% in FY2022 to 13.6% in FY2025.
Based on SEC 10-K filings.
13.6% in FY2025 with a 5-year CAGR of -3.0%.
Improved from 10.9% to 13.6% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +10.8pp
- 5-Year Change
- -3.0pp
- 10-Year Change
- -
Key checks
Key Insights
- UTAH MEDICAL PRODUCTS INC's return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 1.0% year-over-year.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.6% | +1.0% |
| FY2024 | 13.4% | +23.1% |
| FY2023 | 10.9% | +301.5% |
| FY2022 | 2.7% | -78.6% |
| FY2021 | 12.7% | -23.3% |
| FY2020 | 16.6% | +114.2% |
| FY2019 | 7.8% | -36.3% |
| FY2018 | 12.2% | -4.8% |
| FY2017 | 12.8% | -14.1% |
| FY2016 | 14.9% | +3.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026